Vaxart, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Vaxart, Inc. reported Cash And Cash Equivalents At Carrying Value of $34.76 million for the year ending 2023.

  • Vaxart, Inc. showed a decrease of -21.0% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
  • This data is from Vaxart, Inc.'s annual report (Form 10-K), filed with the SEC on March 14, 2024.
  • XBRL data for this metric is available from 2008 to 2023 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q3 2010: $37.28 million | Q4 2010: $53.56 million | Q1 2011: $59.09 million | Q3 2011: $92.95 million | Q4 2011: $57.52 million | Q1 2012: $53.34 million | Q3 2012: $47.10 million | Q4 2012: $74.10 million | Q1 2013: $70.30 million | Q3 2013: $60.80 million | Q4 2013: $51.40 million | Q1 2014: $80.10 million | Q2 2014: $81.70 million | Q3 2014: $57.70 million | Q4 2014: $63.70 million | Q1 2015: $61.50 million | Q3 2015: $45.30 million | Q4 2015: $39.00 million | Q1 2016: $30.60 million | Q2 2016: $49.70 million | Q3 2016: $45.90 million | Q1 2017: $3.29 million | Q2 2017: $2.59 million | Q3 2017: $1.92 million | Q1 2018: $17.50 million | Q2 2018: $23.92 million | Q3 2018: $17.92 million | Q1 2023: $46.83 million | Q3 2023: $33.16 million | Q1 2024: $26.74 million | Q3 2024: $22.04 million.
  • Over the full 18 years of available data (2008 to 2023), Vaxart, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 67.3%.
  • Historical annual values: Fiscal year 2023: $34.76 million | Fiscal year 2022: $44.01 million | Fiscal year 2021: $143.75 million | Fiscal year 2018: $11.51 million | Fiscal year 2017: $1.57 million | Fiscal year 2017: $17.70 million | Fiscal year 2016: $8.41 million | Fiscal year 2016: $49.70 million | Fiscal year 2015: $44.70 million | Fiscal year 2014: $81.70 million | Fiscal year 2013: $66.80 million | Fiscal year 2012: $53.80 million | Fiscal year 2011: $94.31 million | Fiscal year 2011: $74.20 million | Fiscal year 2010: $53.56 million | Fiscal year 2010: $89.80 million | Fiscal year 2009: $59.51 million | Fiscal year 2008: $106.44 million.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: